MENU
+Compare
MAIA
Stock ticker: ASE
AS OF
Jun 5, 04:59 PM (EDT)
Price
$1.93
Change
+$0.17 (+9.66%)
Capitalization
60M

MAIA MAIA Biotechnology Forecast, Technical & Fundamental Analysis

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer... Show more

MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MAIA with price predictions
Jun 04, 2025

Aroon Indicator for MAIA shows an upward move is likely

MAIA's Aroon Indicator triggered a bullish signal on May 13, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 54 similar instances where the Aroon Indicator showed a similar pattern. In of the 54 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MAIA advanced for three days, in of 149 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MAIA moved out of overbought territory on May 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MAIA as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MAIA turned negative on May 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at .

MAIA moved below its 50-day moving average on June 02, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MAIA crossed bearishly below the 50-day moving average on June 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAIA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MAIA broke above its upper Bollinger Band on April 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MAIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.136) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). MAIA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (265.014).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MAIA is expected to report earnings to rise 56.25% to -25 cents per share on August 05

MAIA Biotechnology MAIA Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.12
Q2'24
Missed
by $0.09
The last earnings report on May 05 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 2.33M shares outstanding, the current market capitalization sits at 60.00M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
444 West Lake Street
Phone
+1 312 416-8592
Employees
13
Web
https://www.maiabiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANF79.523.49
+4.59%
Abercrombie & Fitch Co
RVLV22.570.73
+3.34%
Revolve Group
ITW246.11-0.40
-0.16%
Illinois Tool Works
MYPS1.47-0.01
-0.34%
PLAYSTUDIOS
PRE8.21-0.79
-8.78%
Prenetics Global Limited

MAIA and Stocks

Correlation & Price change

A.I.dvisor tells us that MAIA and PCNT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and PCNT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
+0.57%
PCNT - MAIA
27%
Poorly correlated
N/A
LGND - MAIA
27%
Poorly correlated
+1.42%
GOVX - MAIA
26%
Poorly correlated
+6.67%
BYSI - MAIA
26%
Poorly correlated
-0.59%
NRXP - MAIA
25%
Poorly correlated
+8.46%
More